Case report: Changes in serum bevacizumab concentration in a hemodialysis patient with unresectable colorectal cancer treated with FOLFIRI plus bevacizumab

Tanaka, T; Suzuki, H; Ushijima, T; Nagasu, S; Akagi, Y; Kawaguchi, T; Miwa, K

Miwa, K (通讯作者),Kurume Univ Hosp, Multidisciplinary Treatment Canc Ctr, Kurume, Japan.;Miwa, K (通讯作者),Kurume Univ, Dept Surg, Sch Med, Kurume, Japan.

FRONTIERS IN ONCOLOGY, 2022; 12 ():

Abstract

The global incidence of colorectal cancer (CRC) in patients receiving hemodialysis is steadily rising. However, current information on the clinical us......

Full Text Link